IDH1 and central nervous system cancer: The excellent spectral quality obtained at 7T enabled us to detect elevated 2-HG concentrations in glioma patients harboring common (i.e., IDH1 R132H) and rare IDH mutations (i.e., IDH2 R172K and R172W).